VEGF increases retinal vascular ICAM-1 expression in vivo.
暂无分享,去创建一个
K Miyamoto | J. Liao | V. Perez | A. Adamis | H. Peng | A P Adamis | K. Miyamoto | M Lu | V L Perez | N Ma | H B Peng | J K Liao | Hai-bing Peng | N. Ma | M. Lu | Ming Lu | N. Ma | Hai–Bing Peng
[1] D. Hatchell,et al. Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. , 1997, The American journal of the medical sciences.
[2] M. Hart,et al. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55 , 1992, Journal of Neuroimmunology.
[3] D TOUSSAINT,et al. Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.
[4] Joan W. Miller,et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.
[5] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[6] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[7] J. Gass,et al. Spontaneous regression of neovascularization at the disk and elsewhere in diabetic retinopathy. , 1996, American journal of ophthalmology.
[8] R. Bucala,et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.
[9] D. Lefer,et al. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.
[10] M. Wadhwa,et al. Cytokines in sera from insulin‐dependent diabetic patients at diagnosis , 1991, Clinical and experimental immunology.
[11] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[13] G. Schmid-Schönbein,et al. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.
[14] E. Connolly,et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. , 1996, The Journal of clinical investigation.
[15] K Miyamoto,et al. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. , 1998, Investigative ophthalmology & visual science.
[16] R. Jain,et al. During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium , 1996, Nature Medicine.
[17] E S Gragoudas,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[18] M. Madigan,et al. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. , 1996, The American journal of pathology.